PTC Inc. (PTC)

Reports for PTC Inc.

PTC Inc.
PTC
07-08-2025
Read Report
PTC Inc.
PTC
12-05-2025
Read Report
PTC Inc.
PTC
20-04-2025
Read Report

Industries

Technology
108
View Industry
Software
108003
View Industry
Application Software
108003001
View Industry

Analysis

No analyses available for PTC Inc. yet.

Latest News about PTC Inc.

Yahoo
Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches
1750449970 | Yahoo
NASDAQ
Notable Monday Option Activity: GXO, PTC, XP
1745867907 | NASDAQ
NASDAQ
Notable Monday Option Activity: PTCT, EOLS, NOW
1745867903 | NASDAQ
FORBES
5,000 CAPTCHA Tests Used As Infostealer Gateways—Do Not Complete Them
1740829490 | FORBES
OIL&GAS
RNWBL & DSPTCH Announce Partnership to Revolutionize Prevailing Wage & Apprenticeship Compliance...
1739804400 | OIL&GAS
NASDAQ
PTC is Now Oversold
1734989154 | NASDAQ
NASDAQ
Noteworthy Friday Option Activity: JCI, COIN, PTCT
1734725875 | NASDAQ
FOX
From CAPTCHA to catastrophe: How fake verification pages are spreading malware
1734534053 | FOX
NASDAQ
Is PTC Stock Outperforming the Dow?
1734445138 | NASDAQ
NASDAQ
Notable Thursday Option Activity: PTCT, TKO, CLF
1734034745 | NASDAQ
investors
PTC Gets RS Rating Upgrade
1733990400 | investors
NASDAQ
PTC Crosses Above Average Analyst Target
1733401669 | NASDAQ
investors
PTC Getting Closer To Key Technical Benchmark
1733299200 | investors
NASDAQ
PTC, Microsoft And Volkswagen To Develop Generative Artificial Intelligence Copilot
1733233578 | NASDAQ
investors
PTC Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating
1733212800 | investors
investors
PTC Therapeutics Scores A $2.9 Billion Novartis Deal And Hits Profit-Taking Zone
1733149967 | investors
NASDAQ
PTC Inks License And Collaboration Deal With Novartis For PTC518 Huntington's Disease Program
1733143009 | NASDAQ
NASDAQ
PTC To Sell Rare Pediatric Disease Priority Review Voucher For $150 Mln - Quick Facts
1732709542 | NASDAQ
NASDAQ
PTC Stock: Is Wall Street Bullish or Bearish?
1732297224 | NASDAQ
NASDAQ
Guru Fundamental Report for PTC
1732215600 | NASDAQ
AG NEWS
Compañía Nacional de Chocolates Partners with Farmforce to Launch the Traceability and Zero...
1731924900 | AG NEWS
AG NEWS
Compañía Nacional de Chocolates lanza el PTCD con Farmforce como aliado estratégico
1731924900 | AG NEWS
NASDAQ
PTC's Q4 Earnings Surpass Estimates, Revenues Rise Y/Y, Shares Jump
1730986260 | NASDAQ
NASDAQ
PTC (PTC) Q4 2024 Earnings Call Transcript
1730948417 | NASDAQ
NASDAQ
PTC Inc. Q4 Profit Increases, Beats Estimates
1730927156 | NASDAQ
investors
PTC Therapeutics Shows Rising Price Performance With Jump To 95 RS Rating
1728457200 | investors
BIZSTNDRD
Order alert! PTC Ind to supply Titanium Castings for M777; stock rises
1727424334 | BIZSTNDRD
investors
PTC Therapeutics Sees IBD RS Rating Rise To 74
1724828400 | investors
investors
IBD Rating Upgrades: PTC Therapeutics Flashes Improved Relative Price Strength
1724223600 | investors
investors
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
1724095980 | investors
investors
PTC Therapeutics Shows Market Leadership With Jump To 83 RS Rating
1724050800 | investors
BIZSTNDRD
PTC India Q1 results: Net profit rises 33% to Rs 189 cr on lower expenses
1723558794 | BIZSTNDRD
INVESTING
Earnings call: PTC Therapeutics updates on Q2 2024 financials & trials
1723395881 | INVESTING
investors
Stocks With Rising Relative Strength: PTC Therapeutics
1719903600 | investors
investors
PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble
1719605323 | investors
investors
PTC Getting Closer To Key Technical Measure
1719471600 | investors
BIZSTNDRD
SAT stays Sebi order against former PTC India CMD Rajib Kumar Mishra
1719238544 | BIZSTNDRD
investors
PTC Therapeutics Shows Rising Price Performance With Jump To 90 RS Rating
1719212400 | investors
INVESTING
PTC Therapeutics shares target upped by BofA on Huntington's trial data
1718971559 | INVESTING
INVESTING
JPMorgan maintains $53 target on PTC Therapeutics stock
1718906005 | INVESTING
BIZSTNDRD
Former PTC India CMD Rajib Mishra to move SAT against Sebi's order
1718737403 | BIZSTNDRD
investors
Stocks To Watch: PTC Therapeutics Sees Relative Strength Rating Rise To 83
1718348400 | investors
investors
Stocks With Rising Relative Strength: PTC
1718262000 | investors
BIZSTNDRD
Sebi imposes fine of Rs 35 lakh on PTC arm's top brass for governance lapse
1718207939 | BIZSTNDRD
investors
PTC Therapeutics Shows Market Leadership With Jump To 81 RS Rating
1718089200 | investors
BIZSTNDRD
Stocks to Watch, June 11: IndiGo, Siemens India, PTC Industries, APL Apollo
1718073034 | BIZSTNDRD
INVESTING
RaySearch celebrating 10 years of defining state-of-the-art proton planning at PTCOG 62
1717943764 | INVESTING
INVESTING
PTC Inc. chief strategy officer sells over $217k in company stock
1717531462 | INVESTING
investors
PTC Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating
1717138800 | investors
INVESTING
PTC Therapeutics to Participate at Upcoming Investor Conference
1716986164 | INVESTING
BIZSTNDRD
PTC India defers board meeting due to unavailability of subsidiary results
1716984769 | BIZSTNDRD
investors
Stocks Flashing Renewed Technical Strength: PTC
1716447600 | investors
investors
Stocks Flashing Renewed Technical Strength: PTC Therapeutics
1716274800 | investors
INVESTING
PTCT stock target raised, maintains sell rating on favorable regulatory development
1716231463 | INVESTING
INVESTING
PTC Therapeutics stock target raised on re-evaluation of Translarna
1716224656 | INVESTING
investors
PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
1716211366 | investors
BLOOMBERG
Duolingo’s CEO on Language Learning, AI and the End of CAPTCHAs
1714675392 | BLOOMBERG